Literature DB >> 19926867

What is the lifetime risk of physician-diagnosed asthma in Ontario, Canada?

Teresa To1, Chengning Wang, Jun Guan, Susan McLimont, Andrea S Gershon.   

Abstract

RATIONALE: Asthma is the most common chronic respiratory disease in Canada. The estimates of risk of developing asthma may help researchers and health planners set research agendas, predict the burden of asthma on society, and target the at-risk population for asthma prevention, management, and control.
OBJECTIVES: To estimate the lifetime risk of physician-diagnosed asthma.
METHODS: All individuals aged 0-79 years living in Ontario, Canada on April 1, 1996 who had not been diagnosed with asthma were monitored for 11 years until March 31, 2007. They were censored when they were diagnosed with asthma, turned age 80 years, or died. The lifetime risk (from birth to age 79 yr) of physician-diagnosed asthma was calculated by a modified survival analysis technique. Results were stratified by sex, rurality, and neighborhood income.
MEASUREMENTS AND MAIN RESULTS: Overall, the lifetime risk of physician-diagnosed asthma was 33.9%. Whereas the overall lifetime risk was higher in females (35.0 vs. 32.9%; P < 0.001), the cumulative risk was higher in males in early years. The lifetime risk was higher in individuals living in urban areas (34.5 vs. 30.1%; P < 0.001) or low-income neighborhoods (35.0% in the lowest income quintile vs. 32.2% in the highest; P < 0.001).
CONCLUSIONS: Our estimated overall lifetime risk indicates that one of every three individuals in Ontario, Canada has physician-diagnosed asthma during one's lifetime.

Entities:  

Mesh:

Year:  2009        PMID: 19926867     DOI: 10.1164/rccm.200907-1035OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  21 in total

1.  Update in asthma 2010.

Authors:  Shamsah Kazani; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2011-08-01       Impact factor: 21.405

2.  Boswellic acid attenuates asthma phenotypes by downregulation of GATA3 via pSTAT6 inhibition in a murine model of asthma.

Authors:  Zhimin Liu; Xiaoyun Liu; Lili Sang; Haifeng Liu; Qinghua Xu; Zhehui Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

3.  Prevalence and risk factors of asthma in off-reserve Aboriginal children and adults in Canada.

Authors:  Hsiu-Ju Chang; Jeremy Beach; Ambikaipakan Senthilselvan
Journal:  Can Respir J       Date:  2012 Nov-Dec       Impact factor: 2.409

4.  Development and pilot testing of a mobile health solution for asthma self-management: asthma action plan smartphone application pilot study.

Authors:  Christopher Licskai; Todd W Sands; Madonna Ferrone
Journal:  Can Respir J       Date:  2013 Jul-Aug       Impact factor: 2.409

5.  Global asthma prevalence in adults: findings from the cross-sectional world health survey.

Authors:  Teresa To; Sanja Stanojevic; Ginette Moores; Andrea S Gershon; Eric D Bateman; Alvaro A Cruz; Louis-Philippe Boulet
Journal:  BMC Public Health       Date:  2012-03-19       Impact factor: 3.295

6.  Parental socioeconomic status, childhood asthma and medication use--a population-based study.

Authors:  Tong Gong; Cecilia Lundholm; Gustaf Rejnö; Carina Mood; Niklas Långström; Catarina Almqvist
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

7.  Epidemiology of wheeze among preschool children: a population-based cross-sectional study from rural Sri Lanka.

Authors:  Shashanka Indeevara Rajapakse Rajapakse Mudiyanselage; Wadu Arachchige Dharshika Lakmali Amarasiri; Bannek Mudiyanselage Gedara Duminda Yasaratne; Janith Warnasekara; Suneth Agampodi
Journal:  BMJ Open       Date:  2021-07-07       Impact factor: 2.692

8.  Describing and quantifying asthma comorbidity [corrected]: a population study.

Authors:  Andrea S Gershon; Jun Guan; Chengning Wang; J Charles Victor; Teresa To
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

9.  Is asthma a vanishing disease? A study to forecast the burden of asthma in 2022.

Authors:  Teresa To; Sanja Stanojevic; Rachel Feldman; Rahim Moineddin; Eshetu G Atenafu; Jun Guan; Andrea S Gershon
Journal:  BMC Public Health       Date:  2013-03-21       Impact factor: 3.295

10.  The air quality health index and asthma morbidity: a population-based study.

Authors:  Teresa To; Shixin Shen; Eshetu G Atenafu; Jun Guan; Susan McLimont; Brian Stocks; Christopher Licskai
Journal:  Environ Health Perspect       Date:  2012-10-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.